Drawing for CHEMISTRY PLAYBOOK

USPTO serial 77957259

CHEMISTRY PLAYBOOK

Reviewed by CopyMark Law Group

Status 614
Filing date
Status date
Registration date
—
Examiner
YARD, JOHN S
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHEMISTRY PLAYBOOK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical cost management services and drug utilization review servicesACTIVEMar 9, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 25, 2012PETDPETITION TO REVIVE-DENIED—
Oct 18, 2012APETASSIGNED TO PETITION STAFF—
Sep 27, 2012TPDDTEAS DUE DILIGENCE PETITION RECEIVED—
Jul 19, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 19, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 20, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 20, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 20, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 26, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2010DOCKASSIGNED TO EXAMINER—
Mar 18, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 17, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance